NCT06522724

Brief Summary

The planned research will enable the assessment of rehabilitation's effects using two pulmonary rehabilitation models: conventional and supplemented with an education program for patients hospitalized due to pneumonia with confirmed COVID-19.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 26, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

July 26, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 26, 2024

Completed
Last Updated

November 6, 2024

Status Verified

November 1, 2024

Enrollment Period

2 months

First QC Date

July 19, 2024

Last Update Submit

November 4, 2024

Conditions

Keywords

pulmonary rehabilitationCOVID-19pneumoniapatients' education

Outcome Measures

Primary Outcomes (6)

  • Vital capacity (Voldyne 5000)

    Measurements will be performed with certified motivational spirometer, Voldyne 5000. Patient, in a sitting position, will inhale as much air as possible starting from residual volume (RV) level and approach to vital capacity (VC) level. The result will be read from the scale placed on the wall of the device.

    First examination- before the start of the 14-day rehabilitation program

  • Vital capacity (Voldyne 5000)

    Measurements will be performed with certified motivational spirometer, Voldyne 5000. Patient, in a sitting position, will inhale as much air as possible starting from residual volume (RV) level and approach to vital capacity (VC) level. The result will be read from the scale placed on the wall of the device.

    Second examination- at the end of the 14-day rehabilitation program

  • Oxygen saturation

    Measurements will be performed with pulse oximeter and the parameter analyzed will be SpO2 (oxygen saturation by pulse oximetry; percentage of oxygen in patients' blood).

    First examination- before the start of the 14-day rehabilitation program

  • Oxygen saturation

    Measurements will be performed with pulse oximeter and the parameter analyzed will be SpO2 (oxygen saturation by pulse oximetry; percentage of oxygen in patients' blood).

    Second examination- at the end of the 14-day rehabilitation program

  • Acid-base balance

    The gasometry results will be taken from patients' medical documentation. The parameters analyzed will be oxygen pressure (pO2) and carbon dioxide pressure (pCO2).

    First examination- before the start of the 14-day rehabilitation program

  • Acid-base balance

    The gasometry results will be taken from patients' medical documentation. The parameters analyzed will be oxygen pressure (pO2) and carbon dioxide pressure (pCO2).

    Second examination- at the end of the 14-day rehabilitation program

Secondary Outcomes (10)

  • Physical performance assessment by Sit-to-Stand Test (STS)

    First examination- before the start of the 14-day rehabilitation program

  • Physical performance assessment by Sit-to-Stand Test (STS)

    Second examination- at the end of the 14-day rehabilitation program

  • Fatigue assessment using modified Borg scale

    First examination- before the start of the 14-day rehabilitation program

  • Fatigue assessment using modified Borg scale

    Second examination- at the end of the 14-day rehabilitation program

  • Dyspnea assessment with Medical Research Council dyspnea scale

    First examination- before the start of the 14-day rehabilitation program

  • +5 more secondary outcomes

Study Arms (2)

Education program and Pulmonary rehabilitation

EXPERIMENTAL

Conventional pulmonary rehabilitation coupled with original education program.

Other: Education programOther: Pulmonary rehabilitation

Pulmonary rehabilitation

OTHER

Conventional pulmonary rehabilitation

Other: Pulmonary rehabilitation

Interventions

Patients in a study group will participate in daily education program using an original brochure containing information about self-management during the treatment process, the benefits of appropriately adapted physical activity, practical tips on airway clearance techniques or physical exercise.

Education program and Pulmonary rehabilitation

The patients will participate in a 14-day rehabilitation program (Monday to Saturday). Treatments and therapies will be continued for a maximum of three hours daily. The program will be applied individually to each patient and include in-bed assisted exercises, airway clearance techniques, effective cough exercises, pursed-lips breathing, exercises to strengthen the diaphragm and intercostal muscles and cardiopulmonary exercises.

Education program and Pulmonary rehabilitationPulmonary rehabilitation

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalization due to pneumonia due to COVID-19
  • Positive SARS-COV-2 PCR test
  • Independence in in-bed sitting position with lower extremities placed on the floor
  • Age 40 y.o. to 70 y.o.
  • No additional respiratory support (e.a. cardiopulmonary bypass machine, ventilator)
  • Informed, voluntary consent to participate in research.

You may not qualify if:

  • Hospitalization due to pneumonia with negative SARS-COV-2 PCR test
  • Unstable medical condition hindering performing the examination
  • Age under 40 y.o. and over 70 y.o.
  • Cognitive deficits impairing the ability to understand and execute commands
  • Concomitant oncological, neurological, orthopedic, and psychiatric diseases may affect the examined persons' circulatory and respiratory functions, functional efficiency, quality of life, and emotional state.
  • Failure to complete a 14-day rehabilitation program
  • Lack of informed, voluntary consent to participate in research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rzeszów

Rzeszów, 35-959, Poland

Location

MeSH Terms

Conditions

COVID-19Pneumonia

Interventions

Early Intervention, Educational

Condition Hierarchy (Ancestors)

Pneumonia, ViralRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health Services

Study Officials

  • Renata Borys, MSc

    University of Rzeszow

    PRINCIPAL INVESTIGATOR
  • Agnieszka Guzik, A/Prof

    University of Rzeszow

    STUDY DIRECTOR
  • Magdalena Kołodziej, PhD

    University of Rzeszow

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: random selection to two groups (study group and control group)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc

Study Record Dates

First Submitted

July 19, 2024

First Posted

July 26, 2024

Study Start

July 26, 2024

Primary Completion

September 26, 2024

Study Completion

October 26, 2024

Last Updated

November 6, 2024

Record last verified: 2024-11

Locations